Management of Patients With Acute Coronary Syndromes
American College of Cardiology, American College of Emergency Physicians, American Heart Association, Society for Cardiovascular Angiography and InterventionsPublished: February 27, 2025
- Overview of ACS
- Top Take-Home Messages
- ACS Evaluation and Management
- Standard Medical Therapies
- STEMI Management
- Catheterization Laboratory Considerations
- CS Management
- ACS Complications
- Clinical Characteristics of Mechanical Complications of Acute Myocardial Infarction
- In-Hospital Issues
- Discharge
- Figures and Algorithms
- Types and Classification of Acute Coronary Syndromes
- Pathobiology of a Type 1 Myocardial Infarction Due to Atherosclerotic Plaque Disruption
- Initial Assessment of Patients With Suspected ACS
- Initial Choice of P2Y12 Inhibitor in Patients Not Requiring an Oral Anticoagulant
- Management of Lipid-Lowering Therapy for Patients With ACS
- Care System Pathway for Patients Experiencing Ischemic Symptoms Suggestive of ACS
- Selection of a Routine Invasive Versus Selected Invasive Strategy in Patients With NSTE-ACS
- Selection and Timing of an Invasive Strategy in NSTE-ACS
- Core Components of Cardiac Rehabilitation
- DAPT Strategies in the First 12 Months Postdischarge
- Tables
- Electrocardiographic Interpretation for Patients With Suspected Acute Coronary Syndromes
- Types of Acute Myocardial Infarction According to the Universal Definition of Myocardial Infarction
- Selected Risk Stratification Tools for Patients With ACS
- Analgesic Treatment Options for Cardiac Chest Pain
- Dosing Considerations for Oral Antiplatelet Therapy in Patients With ACS
- Management of Oral P2Y12 Inhibitors for Patients Who Require CABG Surgery
- Transition From Intravenous Cangrelor Infusion to Oral P2Y12 Inhibitor
- Dosing of Parenteral Anticoagulation in ACS
- Nonstatin Treatment Options for LDL-C Lowering in Patients With ACS Who Are Not at LDL-C Goal on Maximally Tolerated Statin Therapy
- Statin Classification by Expected LDL-C Reduction
- Fibrin-Specific Fibrinolytic Agents for STEMI
- Relative Contraindications for a Routine Invasive Approach in ACS
- Considerations for Choice of Coronary Revascularization Strategy for Patients With NSTE-ACS and MVD
- LVEF and Patient Characteristics Defining an Indication for Prophylactic ICD Implantation for Primary Prevention in Ischemic Heart Disease
- Clinical Criteria for Diagnosis of Pericarditis
- Additional Therapy for Persistent/Late Pericarditis Symptoms
- Essential Components of Patient Education
- Guidance for ACS Discharge: Best Practices
- Academic Research Consortium High Bleeding Risk Criteria After PCI
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.